Enter your login e-mail to the account
Search
Search parameters
Search results
- Chronic myeloid leukemia – model of successful targeted therapy of oncologic disease
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD
(3-4/2014, Interdisciplinary consilium ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- Management of pacients with CML resistant or intolerant to tyrosine kinase inhibitor – imatinib
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Juraj Halička, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD.
(4/2012, Topic of the year ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(1/2008, Review articles ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Essential thrombocythemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, MUDr. Denisa Jankovičová, MUDr. Tatiana Prigancová, doc. MUDr. Angelika Bátorová, PhD.
(6/2013, Review articles ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Myelofibrosis – diagnosis, management, new treatment options
MUDr. Anna Vallová
(6/2015, Review articles ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Biological therapy in geriatric patients
doc. MUDr. Michal Mego, PhD.
(5/2012, Main topic ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic ) - Myelofibróza – posúdenie nových liečebných možností
MUDr. Antónia Hatalová
(5/2012, Editorial ) - Place of bosutinib in the therapy of chronic myeloid leukemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Angelika Bátorová, PhD.
(3/2016, Drugs & drug classes ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, Review articles ) - Advances in molecular monitoring and the importance of screening BCR/ABL1 mutation for Ph-positive chronic myelocytic leukemia
MUDr. Adriana Kafková, PhD., prof. MUDr. Elena Tóthová, CSc.
(1/2019, Review articles ) - ELN recommendations for management of CML patients 2013
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD.
(4/2014, Review articles ) - Správa z 15. kongresu Európskej hematologickej spoločnosti v Barcelone
MUDr. Ľudmila Demitrovičová
(5/2010, Events ) - Real life data on ponatinib treatment of chronic myeloid leukemia patients in Slovakia
MUDr. Katarína Slezáková, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Iveta Oravcová, PhD., MUDr. Juraj Chudej, PhD., MUDr. Imrich Markuljak, MUDr. Alexander Wild, MUDr. Natália Štecová, prof. MUDr. Elena Tóthová, CSc., MUDr. Eva Mikušková, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2020, Original articles ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles ) - Nilotinib – inhibítor tyrozínkinázy na liečbu chronickej myelocytovej leukémie (CML)
doc. PharmDr. Juraj Sýkora, CSc.
(2/2009, Drugs & drug classes ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - Diagnostics and treatment of essential thrombocytemia – is there yet anything new?
Prof. MUDr. Mikuláš Hrubiško, CSc.
(4/2015, Review articles ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - GASTROINTESTINAL STROMAL TUMOR – A COMPREHENSIVE VIEW OF DIAGNOSTICS AND TREATMENT
MUDr. Andrea Cipková, MPH.
(6/2008, Review articles ) - Therapy for chronic myeloid leukemia: Past, present and future
prof. MUDr. Elena Tóthová, CSc.
(1/2012, Topic of the year ) - Selected epidemiological aspects of chronic lymphocytic leukaemia in Slovakia: results from the cross-sectional study
MUDr. Eva Mikušková, PhD., MUDr. Elena Marušáková, MBA, doc. MUDr. Ľuboš Drgoňa, CSc., MUDr. Emília Flochová, PhD., MUDr. Tomáš Guman, PhD., Prof. MUDr. Mikuláš Hrubiško, CSc., MUDr. Juraj Chudej, PhD., MUDr. Jana Jurkovičová, Prof. MUDr. Eva Králíková, CSc., MUDr. Miroslav Šimek, PhD., MUDr. Natália Štecová, MVDr. Martina Vulganová
(1/2020, Original articles ) - TREATMENT OF CHRONIC MYELOID LEUKEMIA IN KHAT BRATISLAVA DURING 2002 – 2007
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, MUDr. Eva Demečková
(6/2008, Original articles ) - New trends in diagnosis and treatment of essential thrombocythemia and myelofibrosis
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2012, Review articles ) - Indolentné B-bunkové non-Hodgkinove lymfómy – úvodné slovo
Prof. MUDr. Elena Tóthová, CSc.
(1/2017, Spectrum ) - Management of chronic myeloid leukemia after failure of second generation tyrosine kinase inhibitors
MUDr. Katarína Slezáková, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Peter Rohoň, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2022, Review articles ) - The effect of ruxolitinib on quality of life – a case report
MUDr. Daniela Kubincová
(S2/2020, Case reports ) - Esenciálna trombocytémia – mení sa niečo v diagnostike a liečbe v roku 2018?
Prof. MUDr. Mikuláš Hrubiško, CSc.
(4/2018, Spectrum ) - Prognostické faktory pri chronickej lymfocytovej leukémii
MUDr. Ľudmila Demitrovičová, PhD.
(4/2018, Review articles )
- Acne-like rash and another skin toxicities associated with administration of HER1/EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(1/2010, Review articles )
- GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, clearly )